Cargando…

Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid

Recent studies suggest an important role of immunoglobulin E (IgE) as an alternative pathogenic pathway in the development of bullous pemphigoid (BP), as the most frequent subepidermal blistering disease of the skin Use of IgE targeted therapies, such as omalizumab, has been shown promising in recen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyed Jafari, S. Morteza, Gadaldi, Karolina, Feldmeyer, Laurence, Yawalkar, Nikhil, Borradori, Luca, Schlapbach, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702353/ https://www.ncbi.nlm.nih.gov/pubmed/31474990 http://dx.doi.org/10.3389/fimmu.2019.01919

Ejemplares similares

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Human Eosinophils Express the High Affinity IgE Receptor, FcεRI, in Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2014)

Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation
por: Arthur, Greer K., et al.
Publicado: (2022)

Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2020)

Mapping of the CD23 Binding Site on Immunoglobulin E (IgE) and Allosteric Control of the IgE-FcϵRI Interaction
por: Borthakur, Susmita, et al.
Publicado: (2012)

IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients
por: Lamberts, A., et al.
Publicado: (2020)

The High Affinity IgE Receptor FcεRI Is Expressed by Human Intestinal Epithelial Cells
por: Untersmayr, Eva, et al.
Publicado: (2010)

Increasing evidence for omalizumab in the treatment of bullous pemphigoid
por: Lonowski, Sarah, et al.
Publicado: (2020)

The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2019)

TIRF Microscope Image Sequences of Fluorescent IgE-FcεRI Receptor Complexes inside a FcεRI-Centric Synapse in RBL-2H3 Cells
por: Drawbond, Rachel, et al.
Publicado: (2019)

FCεRI Gene Promoter Polymorphisms and Total IgE Levels in Susceptibility to Atopic Dermatitis in Korea
por: Park, Kui Young, et al.
Publicado: (2011)

Single-Cell Measurements of IgE-Mediated FcεRI Signaling Using an Integrated Microfluidic Platform
por: Liu, Yanli, et al.
Publicado: (2013)

Fluorogen-Activating Proteins Provide Tunable Labeling Densities for Tracking FcεRI Independent of IgE
por: Schwartz, Samantha L., et al.
Publicado: (2014)

Carboplatin-induced severe hypersensitivity reaction: Role of IgE-dependent basophil activation and FcεRI
por: Iwamoto, Takuya, et al.
Publicado: (2014)

Blocking of Histamine Release and IgE Binding to FcεRI on Human Basophils by Antibodies Produced in Camels
por: Khaled, Al-Qaoud, et al.
Publicado: (2015)

Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII
por: Rathod, Sanjay, et al.
Publicado: (2019)

Herpetiform aphthous ulcerations induced by secukinumab: Report of 2 cases
por: Benzaquen, Michael, et al.
Publicado: (2020)

IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils
por: Zellweger, Fabian, et al.
Publicado: (2018)

The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells
por: Hirano, Takao, et al.
Publicado: (2018)

Pterygium in bullous pemphigoid: An unusual complication
por: Haneke, Eckart, et al.
Publicado: (2020)

IgE Enhances Mouse Mast Cell FcεRI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions
por: Yamaguchi, Masao, et al.
Publicado: (1997)

Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5)
por: Qiao, Chun Xia, et al.
Publicado: (2009)

Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
por: Vassallo, Camilla, et al.
Publicado: (2022)

Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction
por: Jabs, Frederic, et al.
Publicado: (2018)

Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcεRI signalling
por: Nakamura, Tomoya, et al.
Publicado: (2020)

Proinflammatory and Th2 Cytokines Regulate the High Affinity IgE Receptor (FcεRI) and IgE-Dependant Activation of Human Airway Smooth Muscle Cells
por: Redhu, Naresh Singh, et al.
Publicado: (2009)

IgE-tailpiece associates with α-1-antitrypsin (A1AT) to protect IgE from proteolysis without compromising its ability to interact with FcεRI
por: Quinn, Phyllis M., et al.
Publicado: (2016)

Functional nanoscale coupling of Lyn kinase with IgE-FcεRI is restricted by the actin cytoskeleton in early antigen-stimulated signaling
por: Shelby, Sarah A., et al.
Publicado: (2016)

Quercetin and Resveratrol Differentially Decrease Expression of the High-Affinity IgE Receptor (FcεRI) by Human and Mouse Mast Cells
por: Alam, Syed Benazir, et al.
Publicado: (2022)

Explosive bullous pemphigoid with high serum total IgE: Serum IgE as a biomarker that reflects disease activity
por: Kwon, Hyun Jung, et al.
Publicado: (2018)

Acid Stripping of Surface IgE Antibodies Bound to FcεRI Is Unsuitable for the Functional Assays That Require Long-Term Culture of Basophils and Entire Removal of Surface IgE
por: Galeotti, Caroline, et al.
Publicado: (2020)

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
por: Metz, Martin, et al.
Publicado: (2017)

Effects of a selective casein kinase 1δ and ε inhibitor on FcεRI expression and IgE-mediated immediate-type cutaneous reactions in dogs
por: OHNO, Hikaru, et al.
Publicado: (2019)

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization
por: Mitropoulou, Alkistis N., et al.
Publicado: (2020)

Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid
por: Cole, Connor, et al.
Publicado: (2022)

Regulation of the High Affinity IgE Receptor (FcεRI) in Human Neutrophils: Role of Seasonal Allergen Exposure and Th-2 Cytokines
por: Alphonse, Martin P., et al.
Publicado: (2008)

Soluble IgE‐binding factors in the serum of food‐allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor
por: Steinert, Carolin, et al.
Publicado: (2023)

IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review
por: Saniklidou, Ariadne Hadjikyriacou, et al.
Publicado: (2017)

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
por: Cao, Peng, et al.
Publicado: (2022)

An Interaction Library for the FcεRI Signaling Network
por: Chylek, Lily A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tkk0bhbi1pkpl5j7esh84lnstp